Fueling Innovation

About PrecisionMed

PrecisionMed is a leading supplier of high-quality human biological material for research and we are the largest private global source of longitudinally collected Human Cerebrospinal Fluid from living normal control as well as diseased populations. Since 1996, our accurately-annotated human biological samples have been utilized by pharmaceutical, biotechnology, and academic researchers worldwide.


Scientific Journal Citations


Currently Banked Samples


Customers Served

Guaranteed samples,
with quality you can trust

Each of our high-quality, guaranteed samples is collected through our network of thoroughly-vetted clinical sites under US IRB-approved protocols and is well annotated. Our collections have been part of U.S. NIH grants and have formed the basis of U.S. FDA submissions and subsequent U.S. FDA clearance for diagnostics.


Our Collection Process

Our meticulous, six-step collection process begins with the in-depth validation of our collection sites and ends with you owning 100% of the sample rights, free and clear.


Extensive Donor Data

Every sample includes detailed donor data, such as diagnosis, demographics, donor family medical histories, treatment responses, and disease progression.


Immediate Availability

When we say we have it, we actually have it. All samples are available immediately, and can ship within three (3) days.



Longitudinal Samples

We focus on prospective longitudinal collections of blood products, cerebral spinal fluid, and malignant tissue.


The PrecisionMed Guarantee

If you are dissatisfied, we’ll make it right. Just let us know.

We adhere to the highest standards and stand behind our products and services. PrecisionMed maintains long-term relationships across a network of thoroughly vetted IRB-approved collection sites to guarantee high-quality samples. It’s no wonder research labs like those at Harvard Medical School, Biogen, GlaxoSmithKline, and more use PrecisionMed’s world-class biological materials for their research studies.


World Class Standards

Our standardized procedures allow us to guarantee each sample and to continue to provide the highest quality human biological material for research.



PrecisionMed has been cited in numerous scientific journals as a sample source. View a variety of studies and learn why we’re trusted across the globe.


Own Your Discoveries

Every sample provided by PrecisionMed belongs to the customer after purchase, free of commercial incumbency. You won’t have to pay royalties, instead 100% of the sample rights are yours.


Robust Inventory

PrecisionMed is constantly collecting samples with our predictive biobanking approach. Therefore, we have a robust inventory that is ready to ship immediately.

Meet PrecisionMed’s Executive Team


Dr. Robert Rissman


Robert Rissman’s science research focuses on novel biomarker discovery and experimental neuropathology in Alzheimer’s disease (AD), Parkinson’s disease (PD), and preclinical animal models. In addition to his basic science research program, he also serves as the Director for several cores at UCSD and neighboring USC campus.

He is the Founding Director of UCSD’s Alzheimer’s Disease Cooperative Study (ADCS) Biomarker Core and USC’s Alzheimer’s Therapeutic Research Institute (ATRI) in San Diego, and Alzheimer’s Clinical Trials Consortium (ACTC) which serve AD clinical trials. He is also the Director of UCSD’s Alzheimer’s Disease Research Center (ADRC) Neuropathology and Biomarker Cores and the UCSD ADRC Brain Bank.

He serves as PI at the VA San Diego where his lab is focused on understanding how central corticotropin-releasing factor (CRF) neuromodulatory pathways interplay with peripheral stress signaling and contributes to neuronal vulnerability and AD neuropathology using in vivo pharmacology in transgenic animal models and human biospecimens.

09/08 – present
Associate Professor of Neurosciences, UCSD

04/16 – present
Principal Investigator/Research Biologist, VA San Diego Healthcare System


Dr. Brian Datnow


Dr. Brian Datnow is a graduate of the University of the Witwatersrand Medical School. Following internships in Internal Medicine and Surgery, he completed a residency in Anatomical and Clinical Pathology at the Brigham Hospital (Harvard Medical School) in Boston, MA. and is board certified by the American Board of Pathology.

After 20 years in private practice, he was recruited to the pathology department at the University of California, San Diego. He served as director of the residency program and as interim director of Anatomic Pathology. He attained the level of full professor and recently retired from UCSD with the title of Professor Emeritus.

He has been associated with PrecisionMed since March 2021.


Eric Leach

Co - CEO

Eric is passionate about supporting PrecisionMed’s customers in their efforts to fuel innovation. He is excited everyday by the fact that PrecisionMed’s products and services actively contribute to medical and scientific breakthroughs that improve lives.

Prior to joining PrecisionMed, Eric spent a decade in finance at Goldman Sachs and J.P. Morgan. He advised management teams and boards of directors on strategic matters, capital structure, and mergers and acquisitions within the healthcare and technology industries.

Eric holds an MBA from the University of Michigan and a B.S. in Strategic Management from Brigham Young University.

Eric is originally from Southern California and is an Eagle Scout. He has a passion for live music and all things surf- and ocean-related. Eric most values time with his family, where he and his wife are the proud parents of four young and very spirited children.


Anthony Runco

Co - CEO

Anthony cares deeply about PrecisionMed’s mission to fuel pharma and biotech innovations that improve lives. Anthony, like so many others, knows dear friends and loved ones coping with debilitating conditions.

Prior to joining PrecisionMed, Anthony served in the United States Air Force through the rank of Captain. He has led diverse teams to execute high-pressure missions to improve our military readiness.

Anthony holds an MBA from Harvard Business School, an M.S. from the Air Force Institute of Technology, and a B.S. from Yale University. He is a licensed Professional Engineer.

An Eagle Scout and the proud son of a career NYPD police officer and an NYPD nurse, Anthony was raised in a blue-collar town on the South Shore of Long Island, NY. He recalls 9/11 well. In the aftermath of the tragedy, he witnessed his community come together under the leadership of local business owners, who provided desperately needed goods and services. He has sought to emulate this dedication to community in his own life. To Anthony, friends are family and family are friends.


Ronald Flax

Chief Operating Officer

Mr. Flax is Chief Operating Officer of PrecisionMed, Inc.

Over the past 20 years he has held senior and executive level positions in major European corporations in Operations, Human Resources and Legal Services.

For 9 years, he was a Senior Vice-President of a publicly traded British retailer where he was responsible for Worldwide Operations, Human Resources and Labor Law matters.

He was previously, for 7 years, General Counsel and Head of Human Resources for a London based office equipment manufacturer and distributor.

Mr. Flax is a Law Graduate of the University of Cape Town and formerly practiced as an Attorney of the Supreme Court of South Africa, specializing in corporate transactions and labor law.


Dr. John Flax,

Founder & Chief Medical Officer

Prior to joining PrecisionMed, Inc. as its President and founder, Dr. Flax worked in the pharmaceutical industry in both the United States and United Kingdom.

Dr. Flax has 15 years experience in clinical drug development as director of cardiovascular development at Pfizer, Warner Lambert and Beecham (UK).

His experience includes designing and managing clinical research programs as well as extensive FDA experience including prosecuting new drug applications.

Dr. Flax, while maintaining his position at PrecisionMed, has consulted for numerous US and European pharmaceutical companies and has represented them at FDA.

Apart from the development of FDA submissions and regular FDA interactions, Dr. Flax has conducted several successful FDA Advisory committee meetings.

Dr. Flax was trained in cardiology at St. Mary’s Hospital in London, UK, and holds a MB, ChB from the University of Cape Town, South Africa and membership of the Royal College of Physicians of the United Kingdom (MRCP(UK)).